PL366415A1 - Hamowanie rozwoju komórek guza zależnego od czynnika wzrostu - Google Patents

Hamowanie rozwoju komórek guza zależnego od czynnika wzrostu

Info

Publication number
PL366415A1
PL366415A1 PL01366415A PL36641501A PL366415A1 PL 366415 A1 PL366415 A1 PL 366415A1 PL 01366415 A PL01366415 A PL 01366415A PL 36641501 A PL36641501 A PL 36641501A PL 366415 A1 PL366415 A1 PL 366415A1
Authority
PL
Poland
Prior art keywords
inhibition
tumor cells
growth factor
factor dependency
dependency
Prior art date
Application number
PL01366415A
Other languages
English (en)
Inventor
Rosemarie Lichtner
Ulrike Fuhrmann
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10051609A external-priority patent/DE10051609A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL366415A1 publication Critical patent/PL366415A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL01366415A 2000-10-18 2001-10-17 Hamowanie rozwoju komórek guza zależnego od czynnika wzrostu PL366415A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24101000P 2000-10-18 2000-10-18
DE10051609A DE10051609A1 (de) 2000-10-18 2000-10-18 Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen
PCT/EP2001/012004 WO2002032429A2 (en) 2000-10-18 2001-10-17 Use of inhibitors of progesterone receptor for treating cancer

Publications (1)

Publication Number Publication Date
PL366415A1 true PL366415A1 (pl) 2005-01-24

Family

ID=26007397

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366415A PL366415A1 (pl) 2000-10-18 2001-10-17 Hamowanie rozwoju komórek guza zależnego od czynnika wzrostu

Country Status (25)

Country Link
EP (1) EP1414465B1 (pl)
JP (1) JP4335525B2 (pl)
KR (1) KR20030044006A (pl)
CN (1) CN1311833C (pl)
AT (1) ATE339208T1 (pl)
AU (2) AU1595802A (pl)
BG (1) BG107745A (pl)
BR (1) BR0114677A (pl)
CA (1) CA2423013A1 (pl)
CY (1) CY1106289T1 (pl)
CZ (1) CZ299945B6 (pl)
DE (1) DE60123138T2 (pl)
DK (1) DK1414465T3 (pl)
EA (1) EA005945B1 (pl)
EE (1) EE200300156A (pl)
ES (1) ES2272561T3 (pl)
HR (1) HRP20030386A2 (pl)
HU (1) HUP0301461A3 (pl)
IL (2) IL154974A0 (pl)
MX (1) MXPA03002953A (pl)
NO (1) NO20031745L (pl)
NZ (1) NZ545965A (pl)
PL (1) PL366415A1 (pl)
SK (1) SK4752003A3 (pl)
WO (1) WO2002032429A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5238950A (en) * 1991-12-17 1993-08-24 Schering Corporation Inhibitors of platelet-derived growth factor
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
AR015500A1 (es) * 1997-12-23 2001-05-02 Schering Ag 11 BETA-HALoGENO-ESTRATRIENOS SUSTITUIDOS EN 7 ALFA, PROCEDIMIENTO PARA ELABORAR PREPARADOS FARMACEUTICOS QUE CONTIENEN TALES 11 BETA-HALOGENO-ESTRATRIENOSSUSTITUIDOS EN 7 ALFA, ASI COMO SU UTILIZACION EN LA ELABORACION DE MEDICAMENTOS.
FR2789393B1 (fr) * 1999-02-05 2001-10-12 Centre Nat Rech Scient Lactol steroidique

Also Published As

Publication number Publication date
AU2002215958C1 (en) 2002-04-29
AU1595802A (en) 2002-04-29
HUP0301461A3 (en) 2010-01-28
IL154974A0 (en) 2003-10-31
WO2002032429A3 (en) 2004-02-19
SK4752003A3 (en) 2003-10-07
WO2002032429A2 (en) 2002-04-25
ATE339208T1 (de) 2006-10-15
EE200300156A (et) 2003-08-15
MXPA03002953A (es) 2003-08-07
AU2002215958B2 (en) 2006-08-17
JP4335525B2 (ja) 2009-09-30
HK1071697A1 (en) 2005-07-29
CZ299945B6 (cs) 2008-12-29
NO20031745D0 (no) 2003-04-15
IL154974A (en) 2007-05-15
DE60123138D1 (de) 2006-10-26
DE60123138T2 (de) 2007-09-13
CN1311833C (zh) 2007-04-25
EA200300468A1 (ru) 2003-10-30
JP2004513094A (ja) 2004-04-30
BG107745A (bg) 2004-01-30
ES2272561T3 (es) 2007-05-01
EP1414465B1 (en) 2006-09-13
CA2423013A1 (en) 2002-04-25
CY1106289T1 (el) 2011-10-12
HRP20030386A2 (en) 2005-04-30
HUP0301461A2 (hu) 2003-10-28
CN1551772A (zh) 2004-12-01
NO20031745L (no) 2003-04-15
NZ545965A (en) 2007-09-28
EP1414465A2 (en) 2004-05-06
KR20030044006A (ko) 2003-06-02
BR0114677A (pt) 2003-10-07
DK1414465T3 (da) 2007-01-29
EA005945B1 (ru) 2005-08-25

Similar Documents

Publication Publication Date Title
AU8419201A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
NZ516292A (en) Pyrrolotriazine inhibitors of kinases
IL163777A0 (en) Kinase inhibitors
ZA200106197B (en) Use of glycogen phosphorlase inhibitors to inhibit tumor growth.
YU30003A (sh) Inhibicija zavisnosti faktora rasta na ćelije tumora
IL154974A0 (en) Inhibition of the growth factor dependency of tumor cells
TW200508233A (en) Chk-1 inhibitors
AU2001277524A1 (en) Novel use of inhibitors of the epidermal growth factor receptor
ZA200200390B (en) Use of interleukin-18 inhibitors to inhibit tumor metastasis.
ZA200500423B (en) Use of urease for inhibiting cancer cell growth
AU2003228450A8 (en) Inhibition of tumor growth via peroxiredoxin 3
AU2002228913A1 (en) Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
IL139144A0 (en) Mycobacterial inhibitors
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
NO20034245D0 (no) Aromataseinhibering for å öke kunstig befruktning
PL359727A1 (pl) Krystaliczny preparat farmaceutyczny
IL150128A0 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
UA90254C2 (ru) Производные пиразола и их применение в качестве ингибиторов рецепторных тирозинкиназ
SI1351958T1 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
TW484362U (en) Improved structure of strap for slippers
WO2004026242A3 (en) Substituted ketophosphonate inhibitors of tumor cell proliferation

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)